Results 101 to 110 of about 43,470 (269)

Practices in platelet production: A Nordic perspective (2018–2022)

Vox Sanguinis, EarlyView.
Abstract Background and Objectives The Nordic region includes Denmark, Finland, Iceland, Norway and Sweden, with a population of >27.5 million. Blood services are managed differently in each country. Current data on platelet concentrate (PC) production methods and capacity are important for developing efficiency and cross‐border preparedness. Materials
Aseel Alshamari, Tynngård Nahreen, Jarkko Ihalainen, Ari Hemminki, Ragna Landrö, Erna Knútsdóttir, Betina Sørensen, Elena Danilova, Barbora Jacobsen, Marja‐Kaisa Auvinen, Sofia Ramström, Mohammad R. Abedi   +11 more
wiley   +1 more source

Evidence of meaningful levels of Trypanosoma cruzi in platelet concentrates from seropositive blood. [PDF]

, 2015
BACKGROUND: According to the reported cases of transfusion-acquired Trypanosoma cruzi infection, the risk of T. cruzi transfusion transmission appears to be higher with platelet (PLT) products than with other blood components.
Bula, Ibeth, Cancino Faure, María Beatriz, Fisa Saladrigas, Roser, Girona-Llobera, Enrique, Jimenez-Marco, Teresa, Riera Lizandra, Ma. Cristina   +5 more
core   +2 more sources

From platelets to particles: Optimizing extracellular vesicle isolation in a National Blood Centre

Vox Sanguinis, EarlyView.
Abstract Background and Objectives Platelet‐derived extracellular vesicles (PEVs) are submicron, membrane‐bound particles released upon platelet activation, with a recognized role in haemostasis, inflammation and immunoregulation. PEVs remain insufficiently characterized in blood products.
Y. Chintala, A. Waters, F. McGrath, A. Lorusso, C. Wynne, S. Meaney   +5 more
wiley   +1 more source

Selection of histocompatible apheresis platelet donors by cross- matching random donor platelet concentrates [PDF]

, 1992
BA O’Connell, EJ Lee, K Rothko, M. A. Hussein, CA Schiffer   +4 more
openalex   +1 more source

Monitoring bacterial contamination of blood components at the Croatian Institute of Transfusion Medicine—Evolution of strategies and results in a 14‐year period (2011–2024)

Vox Sanguinis, EarlyView.
Abstract Background and Objectives This study presents the results and experiences of bacterial testing of blood components (BCs) at the Croatian Institute of Transfusion Medicine during the period 2011–2024. Materials and Methods During the 14‐year period, 74,283 BCs were tested.
Ivanka Batarilo, Mia Slade‐Vitkovic, Lidija Rukavina, Jadranka Gulan Harcet, Julijana Ljubicic, Adrijana Grdic, Marko Karlo Radovcic, Matea Vinkovic, Irena Jukic, Tomislav Vuk   +9 more
wiley   +1 more source

Coordinating a bi‐level blood supply chain with interactions between supply‐side and demand‐side operational decisions

International Transactions in Operational Research, Volume 33, Issue 3, Page 1971-2015, May 2026.
Abstract In most blood supply chains, blood centers and hospitals make individual decisions, resulting in an inefficient structure of the blood supply chain, which in turn renders supply and demand matching a challenging exercise. In this work, we make the very first attempt to optimize the interaction between blood centers and hospitals.
Mohammad S. Moshtagh, Yun Zhou, Manish Verma   +2 more
wiley   +1 more source

Newly recognized causes of acute lung injury: transfusion of blood products, severe acute respiratory syndrome, and avian influenza. [PDF]

, 2006
Acute lung injury/acute respiratory distress syndrome (ALI/ARDS) is a clinical syndrome that has an ever-growing list of potential causes. The transfusion of blood products is often a life-saving therapy, but it can be associated with the development of ...
Looney, Mark R
core   +1 more source

Bispecific Antibodies Versus Chimeric Antigen Receptor T‐Cell Therapy in Relapsed/Refractory Diffuse Large B‐Cell Lymphoma: A Comparative Narrative Review of Efficacy, Safety, and Accessibility

Cancer Medicine, Volume 15, Issue 2, February 2026.
ABSTRACT Introduction Diffuse large B‐cell lymphoma (DLBCL) is the most common subtype of non‐Hodgkin lymphoma, and despite advances in frontline therapies such as rituximab, cyclophosphamide, doxorubicin hydrochloride (hydroxydaunorubicin), vincristine sulfate (Oncovin), and prednisone, approximately 30%–40% of patients develop relapsed or refractory (
Dana Sofian Abou, Husna Irfan Thalib, Fayza Akil, Samia Zuhair Sabbagh, Hala Sofian Abou, Mable Pereira, Fatma ElSayed Hassan   +6 more
wiley   +1 more source

Discussion on the recruitment strategy for apheresis platelet donors in Chongqing during a public health emergency*

Frontiers in Public Health
ObjectiveThis study aimed to analyze the population characteristics of apheresis platelet donors in Chongqing Province and provide a scientific basis for the development of precise and efficient recruitment strategies.
Ying Cheng, Chengbing Xie, Yunbo Tian, Fang Wang, Xingchen Liu, Danfeng Cheng   +5 more
doaj   +1 more source

Flaxseed (Linum Usitatissimum L.) Supplementation in Patients Undergoing Lipoprotein Apheresis for Severe Hyperlipidemia—A Pilot Study [PDF]

, 2020
Dominika Kanikowska, Katarzyna Korybalska, Agnieszka Mickiewicz, Rafał Rutkowski, Agnieszka Kuchta, Maki Sato, Ewelina Kreft, Marcin Fijałkowski, Marcin Gruchała, Maciej Jankowski, Andrzej Bręborowicz, Janusz Witowski   +11 more
openalex   +1 more source